除細動器市場の2030年までの予測：タイプ別、患者タイプ別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、除細動器の世界市場は2023年に154億9,000万米ドルを占め、予測期間中にCAGR 8.6%で成長し、2030年には275億米ドルに達する見込みです。

除細動器は、特に心室細動や心室頻拍のような生命を脅かす不整脈の際に、正常な心拍を回復させるために心臓に電気ショックを与えるように設計された医療機器です。これらの異常な心臓のリズムは、心臓を震わせたり拍動を速めたりする原因となり、心停止に至ることがあります。除細動器は、電気ショックを与えることで心臓が再び規則正しいリズムを取り戻し、全身の血液循環が改善されるよう、即座に治療を行うために不可欠なものです。除細動器は、不整脈を管理し、心臓の緊急事態に迅速に対応するために、病院、心臓治療室、救急室、手術室で広く使用されています。

冠動脈疾患財団が2022年に発表した報告書によると、米国では年間約35万6,000件の院外心停止（OHCA）が報告されています。

対象疾患の発生率の増加

世界人口のかなりの部分が、冠動脈疾患や心停止などの心血管疾患の影響を受けています。不整脈性心臓突然死は冠動脈疾患の結果として起こりやすいです。多くの心血管系疾患にかかるリスクは、肥満、高血圧、脂質異常症、糖尿病などの生活習慣によって増加します。加えて、CVDの有病率増加の大きな要因となっているのが、世界の高齢者人口の増加です。心臓の構造と機能が徐々に悪化し複雑化するため、加齢は心室性不整脈の発生を急激に増加させ、その結果、心臓における不整脈の有病率が増加します。これらの要因はすべて、心臓の緊急時にこれらの装置でタイムリーな介入を行う除細動器の需要を促進すると予想されます。

コストと手頃な価格

除細動器は、特に機能や性能が強化された高度なモデルの場合、法外に高価な場合があります。この高額なコストは、財源に制約のあるヘルスケア・プロバイダー、施設、地域にとって課題となり、救命機器への投資能力を制限します。さらに、購入しやすい価格であることが普及とアクセシビリティの妨げとなり、公共スペースや医療機関に除細動器を設置する取り組みの妨げとなっています。コストの障壁に対処することは、特に十分なサービスを受けていない地域社会や資源に制約のあるヘルスケアシステムにおいて、より広範な利用可能性と利用を確保するために極めて重要です。

世界の高齢化

心疾患の発生率と突然の心停止（SCA）のリスクは、世界の高齢者の増加とともに増加しています。高齢化には一般的にさまざまな心臓疾患が伴うため、除細動器の導入は高齢者にとって最も重要です。心臓の緊急事態において、除細動器は心臓の蘇生に不可欠であり、生存の可能性を大幅に高めます。高齢者は心臓発作を起こしやすいため、除細動器は老人介護の現場、老人ホーム、福祉施設、在宅介護で必要性が高まっています。さらに、除細動器は、高齢者人口の需要に対応するために特別に製造された装置など、除細動器技術の発展により、より普及し、広く使用されるようになってきています。メーカーは、高齢者の明確な要件を満たすために年齢に適した除細動器ソリューションを開発するための研究に投資しており、高齢化社会への世界の人口動態の変化と一致する有望な市場機会を生み出しています。

技術的破壊とイノベーション

技術の破壊と革新は除細動器市場に大きな脅威をもたらします。小型化、人工知能、コネクティビティ、先端材料を含む医療技術の急速な進化は、現在の除細動器モデルを時代遅れにするか競合を低下させる可能性があります。ウェアラブル技術とコネクテッド技術は、心臓モニタリングと緊急対応に革命をもたらし、従来の除細動器の必要性を低下させる可能性があります。さらに、再生医療と生体工学の飛躍的進歩は、心臓組織の再生と修復に焦点を当てることで、除細動器に代わる選択肢を提供する可能性があります。こうした技術革新に対応できなければ、市場シェアが低下し、従来の除細動器に対する需要が減少する可能性があります。

COVID-19の影響

COVID-19の大流行は世界の除細動器市場の成長にマイナスの影響を与えると予想されます。パンデミックは病院、特に小病院の購買力にダメージを与え、供給取引や処置のキャンセルや延期につながり、すべての主要除細動器市場競合企業の収入全体に影響を及ぼしました。世界中のヘルスケア・システムが対処しなければならなかった主な問題は、物流の問題、疾病管理、併存疾患や既往症のある患者への優先的な対応、一般市民や病院の最前線で働く人々をCOVID-19からさらに守ることでした。商品やサービスの配送スピードも、最近の包装規制や各国が課すロックダウン・プロセスによって影響を受けた。除細動器市場の製造とサプライ・チェーンは、こうした問題のそれぞれによって悪影響を受ける。

予測期間中、植込み型除細動器セグメントが最大になる見込み

植え込み型除細動器セグメントが最大のシェアを占めると推定されます。植込み型除細動器（ICD）は、不整脈、特に心室性不整脈を監視・管理するために設計された植込み型医療機器です。ICD市場は、心疾患の有病率の増加と高齢化人口の増加により大きな成長を遂げています。ICDは、一次予防（生命を脅かす不整脈を発症するリスクのある人）と二次予防（すでに心イベントを経験した人）の両方に対応しています。さらに、技術の進歩により、遠隔監視や徐脈患者用の統合ペースメーカーなどの機能を備えた、より小型で洗練されたICDが登場しています。さらに、ICDは心臓の不整脈を管理し、患者のQOLを向上させ、死亡率を低下させるという重要な役割を果たし続けており、除細動器市場の重要な構成要素となっています。したがって、除細動器市場には有利な成長が見込まれます。

予測期間中にCAGRが最も高くなると予想されるのは病院、診療所、心臓センター部門です。

病院、診療所、心臓センターセグメントは予測期間中に有利な成長が見込まれます。病院、診療所、心臓センターは、除細動器の採用、利用、流通において極めて重要です。これらは、突然の心停止（SCA）やその他の生命を脅かす不整脈を治療する上で除細動器が不可欠な一次医療ポイントとして機能します。病院や心臓センターでは、除細動器は救急治療室、重症治療室、心臓カテーテル検査室、手術室に不可欠な要素です。さらに、多くの診療所や公的ヘルスケアセンターでは、施設内またはその周辺地域で発生した心臓疾患に対応するため、AEDがすぐに利用できるように設置されています。このような環境では、除細動の有効性と効果を高めるために、除細動器の使用に関する適切な訓練と教育が不可欠です。病院、診療所、心臓センターにおける除細動器の利用可能性とアクセシビリティの確保は、人命救助と心臓治療の成果の向上にとって依然として最も重要です。そのため、この分野の成長を後押ししています。

最大のシェアを占める地域

北米は、主要企業によるイニシアチブ、有利な規制、米国とカナダの技術的に先進的なヘルスケア施設により、予測期間中に最大の市場シェアを占めました。北米は、2022年に42.2％以上の最大の収益シェアを占めました。例えば、ボストン・サイエンティフィック社は、2020年末までに同社のCRT-Dsラインから約33,000台のAutogen、Incepta、Resonate、Cognis、Dynagenを全世界に配備したと述べています。そのうち16,500台が米国だけで登録されていることからも、強力な普及率が見て取れます。米国は除細動器市場を独占しているが、その理由はこの地域のヘルスケア施設が高度に発達しており、研究開発活動への支出が増加しているためです。さらに、突然の心停止による死亡事故を防止する目的で、病院だけでなく、学校、ホテル、道路、鉄道駅などの公共の場所での体外式除細動器の設置が増加していることも、北米で除細動器市場の高いシェアを占める大きな要因となっています。

CAGRが最も高い地域：

アジア太平洋地域は、患者人口の増加、ヘルスケア・インフラの拡大、冠動脈疾患の頻発により、予測期間中に収益性の高い成長が見込まれます。高い除細動器普及率と日本の支援政策が地域拡大を後押ししています。さらに、この地域の患者基盤が拡大し、公共アクセス型除細動器に対する社会的認知が高まった結果、インフラ支出や除細動器普及率の上昇に伴い、この地域の市場開拓が加速するものと思われます。さらに、日本のような国々は、他地域での市場拡大に注力する巨大企業の存在により、除細動器の普及率が高く、これも世界の除細動器市場を拡大する可能性が高いです。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかを提供させていただきます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の除細動器市場：種類別

• 植込み型除細動器
• 体外式除細動器

第6章 世界の除細動器市場：患者タイプ別

• アダルト
• 小児

第7章 世界の除細動器市場：エンドユーザー別

• 病院、診療所、心臓センター
• パブリックアクセス市場
• 代替介護施設
• 入院前ケアの設定
• ホームケア
• 外来手術センター
• その他のエンドユーザー

第8章 世界の除細動器市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Abbott Laboratories, Inc.
• Medtronic
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• ZOLL Medical Corporation
• Schiller AG
• Nihon Kohden Corporation
• StrykerCorporation
• PhilipsHealthcare
• CardiacScienceCorporation
• LivaNovaPLC
• Asahi Kasei Corporation
• Biotronik
• CU Medical System Inc.
• Koninklijke Philips N.V.
• Metrax GmbH
• Progetti srl
• Defibtech LLC
• HeartSine Technologies LLC.
• Mindray Medical International Limited

List of Tables

• Table 1 Global Defibrillator Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 4 Global Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 5 Global Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 6 Global Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 7 Global Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 8 Global Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 9 Global Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 10 Global Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 11 Global Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 12 Global Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 13 Global Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 14 Global Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 15 Global Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 16 North America Defibrillator Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 19 North America Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 20 North America Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 21 North America Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 22 North America Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 23 North America Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 24 North America Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 25 North America Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 26 North America Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 27 North America Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 28 North America Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 29 North America Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 30 North America Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 31 Europe Defibrillator Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 34 Europe Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 35 Europe Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 36 Europe Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 37 Europe Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 38 Europe Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 39 Europe Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 40 Europe Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 41 Europe Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 42 Europe Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 43 Europe Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 44 Europe Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 45 Europe Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 46 Asia Pacific Defibrillator Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 49 Asia Pacific Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 50 Asia Pacific Defibrillator Market Outlook, By Wearable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 51 Asia Pacific Defibrillator Market Outlook, By Manual External Defibrillators (2021-2030) ($MN)
• Table 52 Asia Pacific Defibrillator Market Outlook, By Wearable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 53 Asia Pacific Defibrillator Market Outlook, By Automated External Defibrillator (2021-2030) ($MN)
• Table 54 Asia Pacific Defibrillator Market Outlook, By Semi-Automated External Defibrillator (2021-2030) ($MN)
• Table 55 Asia Pacific Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 56 Asia Pacific Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 57 Asia Pacific Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 58 Asia Pacific Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 59 Asia Pacific Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 60 Asia Pacific Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 61 Asia Pacific Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 62 Asia Pacific Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 63 Asia Pacific Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 64 Asia Pacific Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 65 Asia Pacific Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 66 South America Defibrillator Market Outlook, By Country (2021-2030) ($MN)
• Table 67 South America Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 68 South America Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 69 South America Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 70 South America Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 71 South America Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 72 South America Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 73 South America Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 74 South America Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 75 South America Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 76 South America Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 77 South America Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 78 South America Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 79 South America Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 80 South America Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 81 Middle East & Africa Defibrillator Market Outlook, By Country (2021-2030) ($MN)
• Table 82 Middle East & Africa Defibrillator Market Outlook, By Type (2021-2030) ($MN)
• Table 83 Middle East & Africa Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
• Table 84 Middle East & Africa Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
• Table 85 Middle East & Africa Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
• Table 86 Middle East & Africa Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
• Table 87 Middle East & Africa Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 88 Middle East & Africa Defibrillator Market Outlook, By End User (2021-2030) ($MN)
• Table 89 Middle East & Africa Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
• Table 90 Middle East & Africa Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
• Table 91 Middle East & Africa Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
• Table 92 Middle East & Africa Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
• Table 93 Middle East & Africa Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
• Table 94 Middle East & Africa Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 95 Middle East & Africa Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Defibrillator Market is accounted for $15.49 billion in 2023 and is expected to reach $27.50 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Defibrillators are medical devices designed to deliver an electric shock to the heart in order to restore a normal heartbeat, especially during life-threatening cardiac arrhythmias like ventricular fibrillation or ventricular tachycardia. These abnormal heart rhythms can cause the heart to quiver or beat too fast, leading to cardiac arrest. Defibrillators are vital in providing immediate treatment by administering an electric shock, which helps the heart re-establish a regular rhythm and improves blood circulation throughout the body. Defibrillators are extensively used in hospitals, cardiac care units, emergency rooms, and operating rooms to manage cardiac arrhythmias and to provide rapid response in case of cardiac emergencies.

According to the report published by the Coronary Artery Disease Foundation in 2022, around 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the US.

Market Dynamics:

Driver:

Increasing incidence of the target disorders

A significant portion of the global population are impacted by cardiovascular diseases such coronary artery disease and cardiac arrest. Arrhythmic sudden cardiac death is more likely as a result of coronary artery disease. The risk of acquiring numerous cardiovascular illnesses is mostly increased by lifestyle conditions such obesity, hypertension, dyslipidemia, and diabetes. In addition, a significant contributor in the increased prevalence of CVD is the growing worldwide elderly population. Due to the gradual deterioration and increase in complexity in the structure and function of the heart, ageing is connected with an exponential rise in the development of ventricular arrhythmias, resulting in an increase in the prevalence of arrhythmias in the heart. All these factors are anticipated to propel the demand for defibrillators to provide timely intervention with these devices during cardiac emergencies.

Restraint:

Cost and Affordability

Defibrillator devices can be prohibitively expensive, especially advanced models with enhanced features and capabilities. This high cost poses a challenge for healthcare providers, facilities, and regions with constrained financial resources, limiting their ability to invest in these life-saving devices. Additionally, affordability concerns hinder widespread adoption and accessibility, hampering efforts to equip public spaces and healthcare institutions with defibrillators. Addressing cost barriers is crucial to ensuring broader availability and utilisation, particularly in underserved communities and resource-constrained healthcare systems.

Opportunity:

Global Aging Population

The incidence of cardiac diseases and the risk of sudden cardiac arrest (SCA) rise along with an increase in the number of elderly people worldwide. Defibrillator adoption is of the utmost importance for the senior population because ageing is typically accompanied by a variety of cardiac issues. In cardiac emergencies, defibrillators are essential for reviving the heart, greatly increasing the likelihood of survival. Defibrillators are becoming more necessary in geriatric care settings, nursing homes, assisted living facilities, and at-home care since the elderly are more prone to cardiac episodes. Moreover, defibrillators are becoming more popular and widely used due to developments in defibrillator technology, such as devices made specifically to meet the demands of the senior population. Manufacturers are investing in research to develop age-appropriate defibrillator solutions to meet the distinct requirements of older individuals, creating a promising market opportunity that aligns with the global demographic shift towards an ageing society.

Threat:

Technological Disruption and Innovation

Technological disruption and innovation pose a significant threat to the defibrillator market. The rapid evolution of medical technology, encompassing miniaturization, artificial intelligence, connectivity, and advanced materials, has the potential to render current defibrillator models obsolete or less competitive. Wearable and connected technologies might revolutionize cardiac monitoring and emergency response, potentially reducing the need for traditional defibrillators. Furthermore, breakthroughs in regenerative medicine and bioengineering could offer alternatives to defibrillators by focusing on cardiac tissue regeneration and repair. Failure to keep pace with these innovations could result in declining market share and diminished demand for traditional defibrillators.

COVID-19 Impact

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global defibrillator market. The pandemic damaged hospitals' purchasing power, especially minor hospitals, which led to cancelled or postponed supply deals and procedures, which had an effect on the overall income of all the major defibrillator market competitors. The main issues that healthcare systems around the world had to deal with were logistical issues, sickness management, giving priority to patients with comorbidities and pre-existing problems, and further protecting the general public and hospital frontline workers from COVID-19. The speed of delivery of goods and services was also impacted by more recent packaging restrictions and country-imposed lockdown processes. The manufacturing and supply chain for the defibrillator market are adversely affected by each of these issues.

The Implantable Cardioverter Defibrillators segment is expected to be the largest during the forecast period

The Implantable Cardioverter Defibrillators segment is estimated to hold the largest share. Implantable Cardioverter Defibrillators (ICDs) are implantable medical devices designed to monitor and manage irregular heart rhythms, specifically ventricular arrhythmias. The ICD market has experienced significant growth due to the increasing prevalence of cardiac conditions and a growing ageing population. It caters to both primary prevention (for individuals at risk of developing life-threatening arrhythmias) and secondary prevention (for those who have already experienced cardiac events). Moreover, due to the technological advancements it has smaller and more sophisticated ICDs, with features like remote monitoring and integrated pacemakers for bradycardia patients. Additionally, ICDs continue to play a critical role in managing cardiac arrhythmias, improving patient quality of life, and reducing mortality rates, making them a key component of the defibrillator market. Therefore, there is lucrative growth for the defibrillator market.

The Hospitals, Clinics and Cardiac Centres segment is expected to have the highest CAGR during the forecast period

The Hospitals, Clinics and Cardiac Centres segment is anticipated to have lucrative growth during the forecast period. Hospitals, clinics, and cardiac centres are crucial in the adoption, utilisation, and distribution of defibrillators. They serve as primary points of care where defibrillators are essential in treating sudden cardiac arrest (SCA) and other life-threatening arrhythmias. In hospitals and cardiac centres, defibrillators are integral components of emergency rooms, critical care units, cardiac catheterization labs, and operating rooms. Additionally, many clinics and public healthcare centres have AEDs readily accessible to respond to cardiac events in their facilities or surrounding areas. Proper training and education regarding defibrillator usage are essential in these settings to enhance the efficacy and impact of defibrillation efforts. Ensuring the availability and accessibility of defibrillators in hospitals, clinics, and cardiac centres remains paramount to saving lives and improving cardiac care outcomes. Thus, it is propelling segment growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to initiatives by key players, favourable regulations, and technologically advanced healthcare facilities in the U.S. and Canada. North America held the largest revenue share of more than 42.2% in 2022. For instance, Boston Scientific stated that by the end of 2020, it had deployed about 33,000 Autogen, Incepta, Resonate, Cognis, and Dynagen devices from its CRT-Ds line globally. A strong adoption rate can be seen in the fact that 16,500 of these were registered in the U.S. alone. It dominates the defibrillator market because of the prevailing sophisticated level of healthcare facilities and rising expenditure for research and development activities in this region. Additionally, growing installations of external defibrillators in hospitals as well as in public places such as schools, hotels, streets, railway stations, and others with the aim of preventing fatalities from sudden cardiac arrest is prominently responsible for holding a higher defibrillator market share in North America.

Region with highest CAGR:

Asia-Pacific region is expected to witness profitable growth over the projection period, due to an increasing patient population, an expanding healthcare infrastructure, and the frequency of coronary diseases. A high defibrillator penetration rate and supportive policies in Japan are boosting regional expansion. Additionally, as a result of the region's expanding patient base and growing public awareness of public-access defibrillators, the market in this area will experience faster development as infrastructure spending and defibrillator penetration rise. Moreover, countries such as Japan have a high penetration of defibrillators due to the presence of giant companies that are focused on expanding the market in other geographies, which is also likely to augment the global defibrillator market.

Key players in the market

Some of the key players in the Defibrillator Market include: Abbott Laboratories, Inc., Medtronic, MicroPort Scientific Corporation, Boston Scientific Corporation, ZOLL Medical Corporation, Schiller AG, Nihon Kohden Corporation, StrykerCorporation, PhilipsHealthcare, CardiacScienceCorporation, LivaNovaPLC, Asahi Kasei Corporation, Biotronik, CU Medical System Inc., Koninklijke Philips N.V., Metrax GmbH, Progetti srl, Defibtech LLC, HeartSine Technologies LLC and Mindray Medical International Limited.

Key Developments:

In December 2022, Abbott Launches Navitor™, Its Latest-Generation Transcatheter Aortic Valve Implantation (Tavi) System To Treat Aortic Stenosis In India. Global healthcare company, Abbott announced that it has launched its latest-generation transcatheter aortic valve implantation (TAVI) system, NavitorTM, making the minimally invasive device available for people in India with severe aortic stenosis who are at high or extreme surgical risk.

In September 2022, Abbott Launches New Ensure With Hmb To Help Protect And Strengthen Indian Adults' Muscles. The new Ensure with HMB and 32 nutrients is a clinically-tested, science-based nutritional supplement specially designed to protect and strengthen muscles.

In July 2022, Abbott Launches Grow Right 2.0 Highlighting The Right M-E-A-N-S To Help Parents Foster Holistic Growth In Children. Abbott has launched its Grow Right 2.0 charter introducing M-E-A-N-S guidelines for good practices in Measuring growth, Eating, Activity, Nurturing and Sleep. Abbott's Grow Right 2.0 Charter can help parents address concerns with expert-backed guidelines to help encourage healthy habits in children

Types Covered:

• Implantable Cardioverter Defibrillators
• External Defibrillators

Patient Types Covered:

• Adult
• Pediatric

End Users Covered:

• Hospitals, Clinics and Cardiac Centres
• Public Access Markets
• Alternate Care Facilities
• Pre-hospital Care Settings
• Home Care
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Defibrillator Market, By Type

• 5.1 Introduction
• 5.2 Implantable Cardioverter Defibrillators
• 5.3 External Defibrillators

6 Global Defibrillator Market, By Patient Type

• 6.1 Introduction
• 6.2 Adult
• 6.3 Pediatric

7 Global Defibrillator Market, By End User

• 7.1 Introduction
• 7.2 Hospitals, Clinics and Cardiac Centres
• 7.3 Public access Markets
• 7.4 Alternate Care Facilities
• 7.5 Pre-hospital Care Settings
• 7.6 Home Care
• 7.7 Ambulatory Surgical Centers
• 7.8 Other End Users

8 Global Defibrillator Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Abbott Laboratories, Inc.
• 10.2 Medtronic
• 10.3 MicroPort Scientific Corporation
• 10.4 Boston Scientific Corporation
• 10.5 ZOLL Medical Corporation
• 10.6 Schiller AG
• 10.7 Nihon Kohden Corporation
• 10.8 StrykerCorporation
• 10.9 PhilipsHealthcare
• 10.10 CardiacScienceCorporation
• 10.11 LivaNovaPLC
• 10.12 Asahi Kasei Corporation
• 10.13 Biotronik
• 10.14 CU Medical System Inc.
• 10.15 Koninklijke Philips N.V.
• 10.16 Metrax GmbH
• 10.17 Progetti srl
• 10.18 Defibtech LLC
• 10.19 HeartSine Technologies LLC.
• 10.20 Mindray Medical International Limited